These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 19015382)

  • 21. Pharmacology and Therapeutic Potential of the 5-HT
    Blattner KM; Canney DJ; Pippin DA; Blass BE
    ACS Chem Neurosci; 2019 Jan; 10(1):89-119. PubMed ID: 30020772
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serotonin 5-HT1B and 5-HT1D receptors form homodimers when expressed alone and heterodimers when co-expressed.
    Xie Z; Lee SP; O'Dowd BF; George SR
    FEBS Lett; 1999 Jul; 456(1):63-7. PubMed ID: 10452531
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [3H]5-hydroxytryptamine labels the agonist high affinity state of the cloned rat 5-HT4 receptor.
    Adham N; Gerald C; Schechter L; Vaysse P; Weinshank R; Branchek T
    Eur J Pharmacol; 1996 May; 304(1-3):231-5. PubMed ID: 8813606
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Agonist and antagonist binding to rabbit cortical 5-HT2A receptors: opposite effects of magnesium.
    Aloyo VJ; Salt GL; Hoffman ME; Harvey JA
    Ann N Y Acad Sci; 1998 Dec; 861():280. PubMed ID: 9928290
    [No Abstract]   [Full Text] [Related]  

  • 25. Site-directed mutagenesis of the human 5-HT1B receptor.
    Grånäs C; Nordvall G; Larhammar D
    Eur J Pharmacol; 1998 May; 349(2-3):367-75. PubMed ID: 9671119
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serotonin mechanisms in heart valve disease II: the 5-HT2 receptor and its signaling pathway in aortic valve interstitial cells.
    Xu J; Jian B; Chu R; Lu Z; Li Q; Dunlop J; Rosenzweig-Lipson S; McGonigle P; Levy RJ; Liang B
    Am J Pathol; 2002 Dec; 161(6):2209-18. PubMed ID: 12466135
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dimers of 5HT1 ligands preferentially bind to 5HT1B/1D receptor subtypes.
    Perez M; Jorand-Lebrun C; Pauwels PJ; Pallard I; Halazy S
    Bioorg Med Chem Lett; 1998 Jun; 8(11):1407-12. PubMed ID: 9871775
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Different efficacy of specific agonists at 5-HT3 receptor splice variants: the role of the extra six amino acid segment.
    Niemeyer MI; Lummis SC
    Br J Pharmacol; 1998 Feb; 123(4):661-6. PubMed ID: 9517385
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 5-HT2 receptor subtypes: a family re-united?
    Baxter G; Kennett G; Blaney F; Blackburn T
    Trends Pharmacol Sci; 1995 Mar; 16(3):105-10. PubMed ID: 7792930
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterisation of agonist binding on human 5-HT2C receptor isoforms.
    Quirk K; Lawrence A; Jones J; Misra A; Harvey V; Lamb H; Revell D; Porter RH; Knight AR
    Eur J Pharmacol; 2001 May; 419(2-3):107-12. PubMed ID: 11426831
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heterologous desensitization is evoked by both agonist and antagonist stimulation of the human 5-HT(7) serotonin receptor.
    Krobert KA; Andressen KW; Levy FO
    Eur J Pharmacol; 2006 Feb; 532(1-2):1-10. PubMed ID: 16487959
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The serotonin 5-HT4 receptor. 1. Design of a new class of agonists and receptor map of the agonist recognition site.
    Buchheit KH; Gamse R; Giger R; Hoyer D; Klein F; Klöppner E; Pfannkuche HJ; Mattes H
    J Med Chem; 1995 Jun; 38(13):2326-30. PubMed ID: 7608898
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Signal transduction differences between 5-hydroxytryptamine type 2A and type 2C receptor systems.
    Berg KA; Clarke WP; Sailstad C; Saltzman A; Maayani S
    Mol Pharmacol; 1994 Sep; 46(3):477-84. PubMed ID: 7935328
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High affinity of SDZ HTF-919 related molecules for calf and human caudate 5-HT4 receptors.
    Hoyer D; Fehlmann D; Langenegger D; Kummer J; Giger R; Mattes H; Probst A; Pfannkuche HJ
    Ann N Y Acad Sci; 1998 Dec; 861():267-8. PubMed ID: 9928283
    [No Abstract]   [Full Text] [Related]  

  • 35. Serotonin 2C receptors: suicide, serotonin, and runaway RNA editing.
    Schmauss C
    Neuroscientist; 2003 Aug; 9(4):237-42. PubMed ID: 12934707
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The roles of dopamine and serotonin, and of their receptors, in regulating sleep and waking.
    Monti JM; Jantos H
    Prog Brain Res; 2008; 172():625-46. PubMed ID: 18772053
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 5-HT Receptor Nomenclature: Naming Names, Does It Matter? A Tribute to Maurice Rapport.
    Hoyer D
    ACS Chem Neurosci; 2017 May; 8(5):908-919. PubMed ID: 28269984
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Parallel evaluation of 5-HT1A receptor localization and functionality: autoradiographic studies with [35S]-GTP gamma S and the novel, selective radioligand, [3H]-S 15535.
    Newman-Tancredi A; Chaput C; Touzard M; Verrièle L; Millan MJ
    Ann N Y Acad Sci; 1998 Dec; 861():263-4. PubMed ID: 9928280
    [No Abstract]   [Full Text] [Related]  

  • 39. Serotonin receptors.
    Nichols DE; Nichols CD
    Chem Rev; 2008 May; 108(5):1614-41. PubMed ID: 18476671
    [No Abstract]   [Full Text] [Related]  

  • 40. 5-Hydroxytryptamine receptors.
    Zifa E; Fillion G
    Pharmacol Rev; 1992 Sep; 44(3):401-58. PubMed ID: 1359584
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.